NIH trial demonstrates AI's effectiveness in opioid use disorder care
The study demonstrates the potential for AI to improve access to addiction treatment services. By automating the referral process, AI can help address the shortage of healthcare providers trained in addiction care. This innovative approach could make it easier for individuals struggling with addiction to connect with appropriate resources. The findings highlight the promising role of technology in enhancing healthcare delivery for substance use disorders. This research underscores the importance of integrating AI tools into clinical practice to support better patient outcomes.
NIH-supported Clinical Trial on AI Tool for Referrals to Addiction Specialists
An artificial intelligence (AI)-driven screening tool, developed by a National Institutes of Health (NIH)-funded research team, successfully identified hospitalized adults at risk for opioid use disorder and recommended referral to inpatient addiction specialists. The AI-based method was just as effective as a health provider-only approach in initiating addiction specialist consultations and recommending monitoring of opioid withdrawal.
Compared to patients who received provider-initiated consultations, patients with AI screening had 47% lower odds of being readmitted to the hospital within 30 days after their initial discharge. This reduction in readmissions translated to a total of nearly $109,000 in estimated healthcare savings during the study period.
The study, published in Nature Medicine, reports the results of a completed clinical trial, demonstrating AI's potential to affect patient outcomes in real-world healthcare settings. The study suggests investment in AI may be a promising strategy specifically for healthcare systems seeking to increase access to addiction treatment while improving efficiencies and saving costs.
Comparison between AI Tool and Physician-led Consultations
In a clinical trial, researchers at the University of Wisconsin School of Medicine and Public Health, Madison, compared physician-led addiction specialist consultations to the performance of their AI screening tool, which had been developed and validated in prior work.
Researchers first measured the effectiveness of provider-led consultations at the University Hospital in Madison, Wisconsin, between March to October 2021 and March to October 2022, whereby healthcare providers conducted ad hoc addiction specialist consultations for opioid use disorder. They then implemented the AI screening tool between March to October 2023 to assist the healthcare providers and remind them throughout hospitalization of a patient's need for an addiction specialist's care.
The trial found that AI-prompted consultation was just as effective as provider-initiated consultation, ensuring no decrease in quality while offering a more scalable and automated approach.
AI Screener's Effectiveness and Cost Savings
The AI screener was built to recognize patterns in data, like how our brains process visual information. It analyzed information within all the documentation available in the electronic health records in real-time to identify features and patterns associated with opioid use disorder.
Upon identification, the system issued an alert to providers when they opened the patient's medical chart with a recommendation to order addiction medicine consultation and to monitor and treat withdrawal symptoms.
The trial showed that the AI screener was associated with fewer 30-day readmissions and was cost-effective, resulting in significant healthcare savings. The reduction in readmissions still held after accounting for various factors, indicating the potential for long-term benefits of using AI tools in healthcare settings.
Future of AI in Healthcare
While the AI screener showed strong effectiveness, challenges remain, including potential alert fatigue among providers and the need for broader validation across different healthcare systems. Future research will focus on optimizing the AI tool's integration and assessing its longer-term impact on patient outcomes.
The opioid crisis continues to strain healthcare systems in the U.S., and AI technology has emerged as a novel, scalable tool to potentially overcome these barriers and improve opportunities for early intervention and linkage to medications for opioid use disorder.
If you or someone you know is struggling or in crisis, help is available. Call or text 988 or chat at 988lifeline.org. To learn how to get support for mental health, drug or alcohol conditions, visit FindSupport.gov. If you are ready to locate a treatment facility or provider, you can go directly to FindTreatment.gov or call 800-662-HELP (4357).